-Outlook India has long been the sleeping giant of global agriculture. But its misguided policies while boosting short-term output, yet may transform India into a food importer After decades on the sidelines of international agricultural trade, India was poised last year to become a major food supplier, overtaking traditional exporters of food grain and meat. This could prove to be flash in the pan. The sudden rise and fall of India...

-The Economic Times PATNA: Reserving 33% seats for women in Parliament and state legislatures may remain a dream for Congress president Sonia Gandhi but chief minister Nitish Kumar has not only done that in panchayat bodies of Bihar but is set to take the concept to other areas. Women's support for JD(U) had swelled in elections following the reservations, as the fair sex exhibited approval for the progressive legislation. Encouraged by 'lady...

-The Hindu   High Court has been hearing a petition by non-government organisation After years of harassment from the police and municipal authorities, there is finally some good news for the rickshaw pullers and owners. In compliance with the directions of the Delhi High Court, the East Delhi Municipal Corporation (EDMC) on Wednesday announced a special drive for registration of Cycle-rickshaws and rickshaw pullers through their Citizen Service Bureaus (CSB). Likewise, the North...

-Live Mint Subsidized loans given to farmers through KCCs could very well be the next big source of NPAs for banks Mumbai: A surge in exposure to farm debt through Kisan Credit Cards (KCCs) could emerge as a risk for India's state-run banks, according to experts. Subsidized loans are given to farmers through KCCs by state-owned banks. Until March 2012, the outstanding amount on such loans was`1.6 trillion through 20.3 million cards, as...

-The Economic Times To ensure access to healthcare for all, India must harness innovation in discovering drugs, in developing therapeutics and in delivering affordable healthcare. It is in the light of these facts that one should evaluate the impact of the Indian Supreme Court's ruling in the case involving patent protection for Novartis AG's cancer drug, Glivec. Glivec was the first-of-its-kind cancer drug for leukaemia patients with patent protection in nearly 40...